NasdaqGM - Delayed Quote USD

Structure Therapeutics Inc. (GPCR)

21.79
+0.03
+(0.14%)
At close: June 2 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
182,524
158,228
102,775
52,561
37,696
Operating Income
-182,524
-158,228
-102,775
-52,561
-37,696
Net Non Operating Interest Income Expense
39,580
36,012
13,391
1,257
-122
Pretax Income
-142,944
-122,216
-89,384
-51,304
-37,818
Tax Provision
379
310
236
17
231
Net Income Common Stockholders
-143,323
-122,526
-89,620
-52,836
-43,765
Diluted NI Available to Com Stockholders
-143,323
-122,526
-89,620
-52,836
-43,765
Basic EPS
-2.58
--
-2.43
-1.38
-1.72
Diluted EPS
-2.58
--
-2.43
-1.38
-1.72
Basic Average Shares
55,335.75
--
36,732.67
38,243.18
25,482.17
Diluted Average Shares
55,335.75
--
36,732.67
38,243.18
25,482.17
Total Operating Income as Reported
-182,524
-158,228
-102,775
-52,561
-37,696
Total Expenses
182,524
158,228
102,775
52,561
37,696
Net Income from Continuing & Discontinued Operation
-143,323
-122,526
-89,620
-51,321
-40,008
Normalized Income
-143,323
-122,526
-89,620
-51,321
-40,008
Net Interest Income
39,580
36,012
13,391
1,257
-122
EBIT
-182,524
-158,228
-102,775
-52,561
-37,696
EBITDA
-181,480
-157,236
-102,480
-52,284
-37,624
Reconciled Depreciation
1,044
992
295
277
72
Net Income from Continuing Operation Net Minority Interest
-143,323
-122,526
-89,620
-51,321
-40,008
Normalized EBITDA
-181,480
-157,236
-102,480
-52,284
-37,624
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/3/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MTSR Metsera, Inc.
28.12
+5.24%
 
TERN Terns Pharmaceuticals, Inc.
3.2800
+5.47%
 
CYTK Cytokinetics, Incorporated
31.21
+0.61%
 
ALT Altimmune, Inc.
5.30
-2.39%
 
VKTX Viking Therapeutics, Inc.
26.12
-2.54%
 
MGX Metagenomi, Inc.
1.7600
+3.53%
 
MLTX MoonLake Immunotherapeutics
41.16
+5.51%
 
AKRO Akero Therapeutics, Inc.
50.73
+2.18%
 
PRTA Prothena Corporation plc
4.6600
+1.53%
 
BBIO BridgeBio Pharma, Inc.
35.46
+3.53%